Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025
ALACHUA and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and […]
Axogen Announces Promotions on Research and Development Team
ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing […]
PolyPid Announces Private Placement for $16 Million in Gross Proceeds
PETACH TIKVA, Israel, Jan. 04, 2024 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming […]
Volaris Reports December 2023 Traffic Results: 85% Load Factor
MEXICO CITY, Jan. 04, 2024 (GLOBE NEWSWIRE) — Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS and BMV: […]
Kernel Group Holdings, Inc. Confirms Funding to Extend Period to Consummate Initial Business Combination
New York, Jan. 04, 2024 (GLOBE NEWSWIRE) — Kernel Group Holdings, Inc. (NASDAQ: KRNLU, KRNL, KRNLW) (“KRNL” or the “Company”), […]
Old National Bancorp Announces Schedule for Fourth-Quarter and Full-Year 2023 Earnings Release and Conference Call
EVANSVILLE, Ind., Jan. 04, 2024 (GLOBE NEWSWIRE) — (NASDAQ: ONB) – Old National Bancorp, the holding company of Old National […]
Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
CHARLOTTESVILLE, Va., Jan. 04, 2024 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel […]
Enact to Host Fourth Quarter 2023 Earnings Call February 7th
RALEIGH, N.C., Jan. 04, 2024 (GLOBE NEWSWIRE) — Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its fourth […]
Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma
Partnership Will Utilize Foresight’s Ultra-Sensitive MRD Technology to Identify Patients for Enrollment in Allogene’s ALPHA3 Trial SAN FRANCISCO and BOULDER, […]
DoubleDown Interactive to Participate in iAccess Alpha Virtual MicroCap Conference on January 9th and 10th
SEATTLE, Jan. 04, 2024 (GLOBE NEWSWIRE) — DoubleDown Interactive (NASDAQ: DDI) (“DoubleDown” or the “Company”), a leading developer and publisher […]
